Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: A prospective descriptive study

The Lancet Infectious Diseases

Volumn 13, Issue 1, 2013, Pages 36-42

  Bates, Matthew ^a,b   O'Grady, Justin ^a,b   Maeurer, Markus ^c   Tembo, John ^b   Chilukutu, Lophina ^b   Chabala, Chishala ^d   Kasonde, Richard ^b   Mulota, Peter ^b   Mzyece, Judith ^b   Chomba, Mumba ^b   Mukonda, Lukundo ^b   Mumba, Maxwell ^b   Kapata, Nathan ^b,e   Rachow, Andrea ^f   Clowes, Petra ^f   Hoelscher, Michael ^f,g   Mwaba, Peter ^b,e   Zumla, Alimuddin ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ZAMBIA   (Zambia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

^e MINISTRY OF HEALTH   (Zambia)

^f Mbeya Medical Research Programme (MMRP)   (Tanzania)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ADOLESCENT; AFRICA; ARTICLE; ASSAY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTIDRUG RESISTANT TUBERCULOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPUTUM; STOMACH LAVAGE; XPERT MBT RIF ASSAY;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; GASTRIC LAVAGE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; NASOPHARYNX; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84871084395     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70245-1     Document Type: Article

References (31)

1. Global tuberculosis control: WHO report 2011 2011, WHO, World Health Organisation, Geneva.
2. Zar HJ, Connell TG, Nicol M Diagnosis of pulmonary tuberculosis in children: new advances. Expert Rev Anti Infect Ther 2010, 8:277-288.
3. Eamranond P, Jaramillo E Tuberculosis in children: reassessing the need for improved diagnosis in global control strategies. Int J Tuberc Lung Dis 2001, 5:594-603.
4. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006, 173:1078-1090.
5. Raviglione M, Marais B, Floyd K, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012, 379:1902-1913.
6. Cuevas LE, Browning R, Bossuyt P, et al. Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis 2012, 205(suppl 2):209-215.
7. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012, 205(suppl 2):S199-S208.
8. Kim PS, Makhene M, Sizemore C, Hafner R Viewpoint: challenges and opportunities in tuberculosis research. J Infect Dis 2012, 205(suppl 2):347-352.
9. Perez-Velez CM, Marais BJ Tuberculosis in children. N Engl J Med 2012, 367:348-361.
10. Nicol MP, Zar HJ New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev 2011, 12:16-21.
11. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002, 360:985-990. the UNZA-UCLMS Project Paediatric Post-mortem Study Group.
12. Mudenda V, Lucas S, Shibemba A, et al. Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies. J Infect Dis 2012, 205(suppl 2):s340-s346.
13. Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB 2010, WHO, World Health Organisation, Geneva.
14. Chang K, Lu W, Wang J, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012, 64:580-588.
15. O'Grady J, Bates M, Chilukutu L, et al. Evaluation of the Xpert® MTB/RIF assay at a tertiary referral hospital in a high TB/HIV endemic setting. Clin Infect Dis 2012, 55:1171-1178.
16. Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011, 11:819-824.
17. Zar HJ, Workman L, Isaacs W, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis 2012, 55:1088-1095.
18. Rachow A, Clowes P, Saathoff E, et al. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 2012, 54:1388-1396.
19. Kapata N, Chanda-Kapata P, O'Grady J, et al. Trends of Zambia's tuberculosis burden over the past two decades. Trop Med Int Health 2011, 16:1404-1409.
20. Bates M, O'Grady J, Mwaba P, et al. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS One 2012, 7:e40774.
21. Rachow A, Zumla A, Heinrich N, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay-a clinical validation study. PLoS One 2011, 6:e20458.
22. Lauritsen J, Bruus M EpiData Entry (27 January 2008). A comprehensive tool for validated entry and documentation of data 2008, The EpiData Association, Odense, Denmark.
23. Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012, 40:442-447.
24. Lawn SD, Zumla AI Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay. Expert Rev Anti Infect Ther 2012, 10:631-635.
25. McNerney R, Maeurer M, Abubakar I, et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis 2012, 205(suppl 2):147-158.
26. Zar HJ, Hanslo D, Apolles P, Swingler G, Hussey G Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005, 365:130-134.
27. Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational 'How-to'; practical considerations 2011, WHO, World Health Organisation, Geneva.
28. Blakemore R, Nabeta P, Davidow AL, et al. A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. Am J Respir Crit Care Med 2011, 184:1076-1084.
29. Performance of Xpert MTB/RIF version G4 assay 2011, FIND, Foundation for Innovative New Diagnostics, Geneva.
30. Lawn SD, Nicol MP Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 2011, 6:1067-1082.
31. WHO. Guidance for national tuberculosis programmes on the management of tuberculosis in children; 2006.